Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Ascendis Pharma A/S (ASND) – Ascendis Pharma A/S Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Ascendis Pharma (ASND) trades at $244.48, up 0.63% on the day, with a bullish technical outlook and strong analyst consensus. Recent FDA approval for YUVIWEL in achondroplasia and positive clinical trial data support growth prospects, though the company remains unprofitable with negative margins and high debt levels.
The stock offers significant upside to the $294.86 consensus price target, driven by commercial launches and pipeline advancements, but carries high risk due to persistent losses, cash burn, and competitive pressures in rare disease therapeutics.
Read full analysis

Key Stats

  • Market Cap
    $15.01B
  • Sector
    Health
  • 3M Drawdown
    -10.97%
  • Enterprise Value
    $15.31B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    49 days
$244.77
52W Low: $151.25
09 May 2025
52W High: $249.84
14 Apr 2026

Ascendis Pharma A/S (ASND) is currently valued at a market capitalization of $15.01B, with an enterprise value of $15.31B. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $151.25 and a high of $249.84, highlighting its annual price range. Over the past three months, Ascendis Pharma A/S has recorded a drawdown of -10.97%, reflecting recent price volatility. On average, investors hold Ascendis Pharma A/S for approximately 49 days, indicating typical investor behavior on the platform.

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.


Technical Indicators
|
|
|
Overall Summary
Bearish (16)Neutral (4)Bullish (7)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $15.01B
  • Sector
    Health
  • 3M Drawdown
    -10.97%
  • Enterprise Value
    $15.31B
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    49 days
$244.77
52W Low: $151.25
09 May 2025
52W High: $249.84
14 Apr 2026

Ascendis Pharma A/S (ASND) is currently valued at a market capitalization of $15.01B, with an enterprise value of $15.31B. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $151.25 and a high of $249.84, highlighting its annual price range. Over the past three months, Ascendis Pharma A/S has recorded a drawdown of -10.97%, reflecting recent price volatility. On average, investors hold Ascendis Pharma A/S for approximately 49 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!